Skip to content
TrialScanner

NCT03529942

Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee

Phase 3CompletedPCRXLead

Registry record

Lead sponsor
Pacira Pharmaceuticals, Inc
Conditions
Osteoarthritis, Knee
Primary completion
Nov 8, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03529942 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.